Additionally, the infusion improved key biochemical markers, including total lipids, triglycerides, cholesterol, SGPT, SGOT, and glucose levels, indicating its potential for preventing non-alcoholic fatty liver disease (NAFLD), hyperlipidemia, and hyperglycemia. Here, GOT1 is linked to metabolic dysfunction-associated steatotic liver disease.